[Indications for immunosuppression by use of cytostatics in ophthalmology].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016039:Corneal Transplantation; D003520:Cyclophosphamide / Q000627:therapeutic use; D005128:Eye Diseases / Q000628:therapy*; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009002:Monomethylhydrazine; D014184:Transplantation, Homologous; D014605:Uveitis / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D014750:Vincristine; D003520:Cyclophosphamide; D001379:Azathioprine; D009002:Monomethylhydrazine; D008727:Methotrexate
Indications de l'immunosuppression par cytostatiques en ophtalmologie